Skip to Content


In the US, Aldesleukin (aldesleukin systemic) is a member of the following drug classes: interleukins, miscellaneous antineoplastics and is used to treat Melanoma, Melanoma - Metastatic and Renal Cell Carcinoma.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antineoplastic agent

Biological response modifier, BRM


Chemical Names

125-L-serine-2-133-interleukin 2 (human reduced) (WHO)

2-133-Interleukin 2 (human reduced), 125-L-serine- (USAN)

Des-alanyl-1, serine-125 human interleukin-2 (BAN)

Foreign Names

  • Aldesleukinum (Latin)
  • Aldesleukin (German)
  • Aldesleukine (French)
  • Aldesleukina (Spanish)

Generic Names

  • Aldesleukin (OS: BAN, USAN)
  • Aldesleukine (OS: DCF)
  • IL-2 (IS)
  • Interleukin-2 human (IS: 1-des-Ala, 125 Ser)
  • recombinant human interleukin-2 (IS)
  • r-serHulL-2 (IS)

Brand Names

  • Proleukin
    Chiron, Egypt; Novartis, Belgium; Novartis, Czech Republic; Novartis, Denmark; Novartis, Finland; Novartis, France; Novartis, Greece; Novartis, Hungary; Novartis, Iceland; Novartis, Lithuania; Novartis, Netherlands; Novartis, Portugal; Novartis, Turkey; Novartis, Taiwan; Novartis Consumer Health, United States; Novartis Farma, Italy; Novartis Farmaceutica, Spain; Novartis Pharma, Austria; Novartis Pharma, Switzerland; Novartis Pharma, Israel; Novartis Pharma, Lebanon; Novartis Pharmaceuticals, Canada; Novartis Pharmaceuticals UK, United Kingdom; Prometheus, United States; Tecnofarma, Ecuador; Zodiac, Brazil
  • Proleukin Hyupjin
    Hyup Jin, South Korea
  • Proleukin S
    Novartis Pharma, Germany
  • Xin Mei Ge
    CP Guojian Pharmaceutical, China


BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.